Related references
Note: Only part of the references are listed.Theoretical aspects on the use of single-time-point dosimetry for radionuclide therapy
Johan Gustafsson et al.
PHYSICS IN MEDICINE AND BIOLOGY (2022)
Overview of the 2022 WHO Classification of Thyroid Neoplasms
Zubair W. Baloch et al.
ENDOCRINE PATHOLOGY (2022)
A Novel Time-Activity Information-Sharing Approach Using Nonlinear Mixed Models for Patient-Specific Dosimetry with Reduced Imaging Time Points: Application in SPECT/CT After 177Lu-DOTATATE
Theresa P. Devasia et al.
JOURNAL OF NUCLEAR MEDICINE (2021)
Feasibility of Single-Time-Point Dosimetry for Radiopharmaceutical Therapies
Xinchi Hou et al.
JOURNAL OF NUCLEAR MEDICINE (2021)
Radiation Dosimetry in Lu-177-PSMA-617 Therapy Using a Single Posttreatment SPECT/CT Scan: A Novel Methodology to Generate Time- and Tissue-Specific Dose Factors
Price A. Jackson et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Dosimetry after peptide receptor radionuclide therapy: impact of reduced number of post-treatment studies on absorbed dose calculation and on patient management
Alexandre Chicheportiche et al.
EJNMMI PHYSICS (2020)
Personalized radiation dosimetry for PRRT-how many scans are really required?
Nanette Freedman et al.
EJNMMI PHYSICS (2020)
Kidney dosimetry in 777 patients during 177Lu-DOTATATE therapy: aspects on extrapolations and measurement time points
Mattias Sandstrom et al.
EJNMMI PHYSICS (2020)
Technical Note: Simplified and practical pretherapy tumor dosimetry - A feasibility study for 131I-MIBG therapy of neuroblastoma using 124I-MIBG PET/CT
Youngho Seo et al.
MEDICAL PHYSICS (2019)
Accuracy of kidney dosimetry performed using simplified time activity curve modelling methods: a 177Lu-DOTATATE patient study
Wei Zhao et al.
PHYSICS IN MEDICINE AND BIOLOGY (2019)
Dose Mapping After Endoradiotherapy with Lu-177-DOTATATE/DOTATOC by a Single Measurement After 4 Days
Heribert Haenscheid et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Technical Note: Single time point dose estimate for exponential clearance
Mark T. Madsen et al.
MEDICAL PHYSICS (2018)
Accuracy and reproducibility of simplified QSPECT dosimetry for personalized 177Lu-octreotate PRRT
Michela Del Prete et al.
EJNMMI PHYSICS (2018)
Feasibility and accuracy of single time point imaging for renal dosimetry following 177Lu-DOTATATE (Lutate') therapy
Kathy P. Willowson et al.
EJNMMI PHYSICS (2018)
Iodine Symporter Targeting with 124I/131I Theranostics
James Nagarajah et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
131I activity quantification of gamma camera planar images
Raquel Barquero et al.
PHYSICS IN MEDICINE AND BIOLOGY (2017)
Ten Year Experience of Radioiodine Dosimetry: is it Useful in the Management of Metastatic Differentiated Thyroid Cancer?
F. Sun et al.
CLINICAL ONCOLOGY (2017)
124I PET/CT to Predict the Outcome of Blind 131I Treatment in Patients with Biochemical Recurrence of Differentiated Thyroid Cancer: Results of a Multicenter Diagnostic Cohort Study (THYROPET)
Jakob W. Kist et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
124I PET Assessment of Response of Bone Metastases to Initial Radioiodine Treatment of Differentiated Thyroid Cancer
Walter Jentzen et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Dose-Response Relationship in Differentiated Thyroid Cancer Patients Undergoing Radioiodine Treatment Assessed by Means of 124I PET/CT
Roel Wierts et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
124I PET/CT in Patients with Differentiated Thyroid Cancer: Clinical and Quantitative Image Analysis
Seza A. Gulec et al.
THYROID (2016)
Assessment of Lesion Response in the Initial Radioiodine Treatment of Differentiated Thyroid Cancer Using 124I PET Imaging
Walter Jentzen et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
Alan L. Ho et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The Impact of Distant Metastases at Presentation on Prognosis in Patients with Differentiated Carcinoma of the Thyroid Gland
Iain J. Nixon et al.
THYROID (2012)
Physical Performance of the new hybrid PET/CT Discovery-690
V. Bettinardi et al.
MEDICAL PHYSICS (2011)
Optimized 124I PET dosimetry protocol for radioiodine therapy of differentiated thyroid cancer
Walter Jentzen et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Partial-volume effect in PET tumor imaging
Marine Soret et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: Benefits and limits of radioiodine therapy
C. Durante et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
RET/PTC-induced dedifferentiation of thyroid cells is mediated through Y1062 signaling through SHC-RAS-MAP kinase
JA Knauf et al.
ONCOGENE (2003)
Share Paper
